Get started
AtriCure, Inc.AtriCure, Inc.AtriCure, Inc.

AtriCure, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ATRC chart


Full chart

ATRC upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.62 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.81 USD
Net income (FY)
‪−44.70 M‬ USD
Revenue (FY)
‪465.31 M‬ USD
Shares float
‪47.75 M‬
Beta (1Y)
1.02

Employees


Employees (FY)
‪1.3 K‬
Change (1Y)
+100 +8.33%
Revenue / Employee (1Y)
‪357.93 K‬ USD
Net income / Employee (1Y)
‪−34.38 K‬ USD

About AtriCure, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Michael H. Carrel
Website
atricure.com
Headquarters
Mason
Founded
1994
FIGI
BBG000BL6CB5
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ATRC news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ATRC.

Frequently Asked Questions


The current price of ATRC is 32.71 USD — it has increased by 1.27% in the past 24 hours. Watch AtriCure, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AtriCure, Inc. stocks are traded under the ticker ATRC.
ATRC stock has risen by 4.50% compared to the previous week, the month change is a 2.38% rise, over the last year AtriCure, Inc. has showed a 47.54% increase.
We've gathered analysts' opinions on AtriCure, Inc. future price: according to them, ATRC price has a max estimate of 60.00 USD and a min estimate of 40.00 USD. Watch ATRC chart and read a more detailed AtriCure, Inc. stock forecast: see what analysts think of AtriCure, Inc. and suggest that you do with its stocks.
ATRC reached its all-time high on Nov 5, 2021 with the price of 89.18 USD, and its all-time low was 1.00 USD and was reached on Apr 24, 2009. View more price dynamics on ATRC chart.
See other stocks reaching their highest and lowest prices.
ATRC stock is 2.68% volatile and has beta coefficient of 1.02. Track AtriCure, Inc. stock price on the chart and check out the list of the most volatile stocks — is AtriCure, Inc. there?
Today AtriCure, Inc. has the market capitalization of ‪1.62 B‬, it has increased by 3.86% over the last week.
Yes, you can track AtriCure, Inc. financials in yearly and quarterly reports right on TradingView.
AtriCure, Inc. is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ATRC earnings for the last quarter are −0.14 USD per share, whereas the estimation was −0.23 USD resulting in a 37.78% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about AtriCure, Inc. earnings.
AtriCure, Inc. revenue for the last quarter amounts to ‪123.62 M‬ USD, despite the estimated figure of ‪122.90 M‬ USD. In the next quarter, revenue is expected to reach ‪130.17 M‬ USD.
ATRC net income for the last quarter is ‪−6.75 M‬ USD, while the quarter before that showed ‪−15.57 M‬ USD of net income which accounts for 56.66% change. Track more AtriCure, Inc. financial stats to get the full picture.
No, ATRC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 17, 2025, the company has ‪1.3 K‬ employees. See our rating of the largest employees — is AtriCure, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AtriCure, Inc. EBITDA is ‪−3.69 M‬ USD, and current EBITDA margin is −1.99%. See more stats in AtriCure, Inc. financial statements.
Like other stocks, ATRC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AtriCure, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AtriCure, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AtriCure, Inc. stock shows the neutral signal. See more of AtriCure, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.